title: [Interdisciplinary treatment measures in pulmonary metastasis of uterine cancer: initial results in 61 patients].
abstract: In the period between January, 1976 and December, 1987, 61 patients with a carcinoma of the uterus that had metastasized to the lungs were treated at the Ruhrlandklinik in Essen-Heidhausen, in a cooperative effort with the West German Tumour Center in Essen. The metastases were asynchronous and the pulmonary lesions manifested up to 18 years after surgical treatment of the primary tumour. No 30-day mortality was observed. In the case of solitary metastasis, no post-operative adjuvant therapy was, as a rule, applied; in the case of multiple metastases, even after they had been radically removed, hormone therapy alone or in combination with a four- to six-fold repeated adjuvant chemotherapy was applied in individual cases. The five-year survival rate for patients with solitary metastases was 57%, in those with multiple metastases receiving adjuvant chemotherapy 27%. None of the patients who received a pleurectomy for carcinoma-induced pleuritis survived for five years.
authors.affiliation: Abteilung für Thoraxchirurgie und thorakale Endoskopie, Ruhrlandklinik, Essen-Heidhausen.
authors.forename: M
authors.initials: M
authors.lastname: Zink
authors.forename: D
authors.initials: D
authors.lastname: Greschuchna
authors.forename: N
authors.initials: N
authors.lastname: Niedèrle
authors.forename: G
authors.initials: G
authors.lastname: Stamatis
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary* / Q000601:surgery; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000556:secondary* / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008175:Lung Neoplasms / Q000556:secondary*; D008207:Lymphatic Metastasis; D008875:Middle Aged; D011013:Pneumonectomy; D012189:Retrospective Studies; D002583:Uterine Cervical Neoplasms / Q000601:surgery*; D014594:Uterine Neoplasms / Q000601:surgery*
vernacular_title: Interdisziplinäre Behandlungsmassnahmen bei pulmonal metastasierendem Uteruskarzinom: Erste Ergebnisse bei 61 Patientinnen.